Geldanamycin is an antibiotic and a potent antitumor compound. It inhibits pp60src tyrosine kinase, and it also binds specifically to heat shock protein Hsp90 and its GP96 homologue. It is known to inhibit protein maturation.
This report contains market size and forecasts of Geldanamycin in global, including the following market information:
Global Geldanamycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Geldanamycin Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Geldanamycin companies in 2021 (%)
The global Geldanamycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Geldanamycin include Thermo Fisher Scientific, Abcam, Merck, Cayman Chemical, Enzo Biochem, BioVision, AG Scientific, Selleck Chemicals and APExBIO Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Geldanamycin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Geldanamycin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Geldanamycin Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Geldanamycin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Geldanamycin Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Geldanamycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Geldanamycin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Geldanamycin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Geldanamycin revenues share in global market, 2021 (%)
Key companies Geldanamycin sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Geldanamycin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Abcam
Merck
Cayman Chemical
Enzo Biochem
BioVision
AG Scientific
Selleck Chemicals
APExBIO Technology
Cell Signaling Technology
BPS Bioscience
STEMCELL Technologies
Bio-Techne
Santa Cruz Biotechnology
Carl Roth
Adooq Bioscience
FERMENTEK
Cell Guidance Systems
PromoCell
Beyotime